510(k) Report

510(k) · Cleared

Cleared

Precious Plus Guide Catheter

K072316510(k) SpecialCleared Sep 17, 200731-day reviewClass II21 CFR 870.1250

Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) Sep 30, 2026 (MAUDE) refreshed weekly, last Nov 3, 2026

Asahi Intecc Co., Ltd. · DQY Catheter, Percutaneous

Cleared on Sep 17, 2007 as substantially equivalent to K061601 (Asahi Intecc Co., Ltd., 2006) and 1 other predicate after a 31-day review. Its family tree reaches back 3 generations to 2001.

Decided
Sep 17, 2007
Review
31 days
Class
Class II
Product code
DQY
Recalls
None
Predicates
2

Its longest line of descent runs back 3 generations to K010874 (2001). 5 ancestors in all, the oldest K953987 (1995). No later device cites it as a predicate yet.

  1. Root · 3 generations backK010874 6F Mach 1, Model 34356-XXXBoston Scientific Corp · 2001 · Recalled
  2. 2 generations backK020028 6F MACH1/34356-XXX; 5F MACH1/35845-XXX; 7F MACH1/34357-XXX; 8F…Boston Scientific · 2002 · Recalled
  3. 1 generation backK061601 Asahi Precious Guide CatheterAsahi Intecc Co., Ltd. · 2006
  4. This deviceK072316 Precious Plus Guide CatheterAsahi Intecc Co., Ltd. · 2007
View FIG. 1 as a table

Line of descent and top descendants

GenerationNumberDeviceApplicantDecidedRecalls
−3K0108746F Mach 1, Model 34356-XXXBoston Scientific Corp200111
−2K0200286F MACH1/34356-XXX; 5F MACH1/35845-XXX; 7F MACH1/34357-XXX; 8F MACH1/34358-XXXBoston Scientific200211
−1K061601Asahi Precious Guide CatheterAsahi Intecc Co., Ltd.2006—
0 (this device)K072316Precious Plus Guide CatheterAsahi Intecc Co., Ltd.2007—

Other ancestors by year cleared

Year clearedDevicesWith a Class I recall
199510
199710
FIG. 1 — Lineage of K072316, 2001–2007Source: FDA 510(k) summaries, read by 510(k) Report · How lineage is built

Get the monthly Device Review Tracker

Notable FDA decisions, review times and new Class I recalls. See an issue.

Sources: FDA 510(k) database (decision fields), the FDA summary (predicates and indications), FDA recall and enforcement reports, and MAUDE; processed by 510(k) Report. Verify on FDA.gov · Methodology and accuracy.

Planning a device in DQY? A 510(k) Report weighs predicate choices, recall history and review times for a new device like this one.

Top candidate predicates for a new DQY device

  1. #1 K234115 APRO 55 Catheterscore 17.5 · 6 generations · no Class I recall
  2. #2 Held for the reportin the report
  3. #3 Held for the reportin the report
Get a 510(k) Report

What was it cleared against? (2)

Devices the submitter claimed this one is substantially equivalent to (*), and reference devices cited for a specific test or feature (†), as written in the FDA summary.

TypeNumberDeviceApplicantDecidedRecalls
*K061601Asahi Precious Guide Catheter
Summary page 1
…Percutaneous Catheter DEVICE Class 2 per 21 CFR §870.1250 CLASSIFICATION: PRODUCT CODE DQY PREDICATE DEVICE: Asahi Precious Guide Catheter - K061601 Guidant ACS Viking Guiding Catheter - K972484 DESCRIPTION OF THE DEVICE SUBJECT TO PREMARKET NOTIFICATION: T…
Asahi Intecc Co., Ltd.2006—
*K972484Acs Viking Guiding Catheter
Summary page 1
…21 CFR §870.1250 CLASSIFICATION: PRODUCT CODE DQY PREDICATE DEVICE: Asahi Precious Guide Catheter - K061601 Guidant ACS Viking Guiding Catheter - K972484 DESCRIPTION OF THE DEVICE SUBJECT TO PREMARKET NOTIFICATION: The Precious plus guide catheter is intended for use in coronary…
Guidant Corp.19972

Also cleared against K061601: 2 other devices →

What descends from it?

No later submission names this one as a predicate yet.

Has anything in its family been recalled? (0 Class I)

No FDA recall names this device.

No ancestor or descendant has a Class I recall.

What does this lineage say?

  • The line of descent spans 6 years and passes through 3 companies; a new generation was cleared every 10 months on median.
  • 3 of the 5 ancestors have a recall of any class.
  • 2 other devices also cite its predicate K061601.

How does its category compare?

All DQY devices

DQY Catheter, Percutaneous: FDA decisions, review times, recalls and adverse event reports over 20 years. 2007, this device’s year, is highlighted.

FDA decisions per year · DQY

21in 2025

2007: 162008: 312009: 372010: 222011: 362012: 302013: 322014: 192015: 272016: 222017: 262018: 252019: 302020: 202021: 182022: 182023: 182024: 162025: 212026 (partial year): 11
2007high 37 (2009) · low 16 (2007)2026

2026 to Oct 25, outlined.

Median 510(k) review, days · DQY

115in 2025

2007: 85 days median2008: 66 days median2009: 73 days median2010: 74 days median2011: 71 days median2012: 87 days median2013: 92 days median2014: 127 days median2015: 118 days median2016: 117 days median2017: 113 days median2018: 106 days median2019: 111 days median2020: 120 days median2021: 81 days median2022: 74 days median2023: 114 days median2024: 87 days median2025: 115 days median2026 (partial year): 30 days median
2007high 127 (2014) · low 66 (2008)2026

Receipt to decision; years with fewer than 3 clearances left blank.

Recalls per year · DQY

1in 2025

2007: 62008: 122009: 172010: 322011: 62012: 22013: 36, 1 Class I2014: 32015: 32016: 22, 7 Class I2017: 82018: 22019: 12020: 22021: 22023: 172024: 12025: 1, 1 Class I2026 (partial year): 2, 1 Class I
2007high 36 (2013) · low 0 (2022)2026

Class I (10 since 2007) Class II/III not classified

Adverse event reports per year · DQY

3,056in 2025

2007: 3132008: 4962009: 8192010: 1,2932011: 1,2112012: 1,1912013: 1,3522014: 1,4972015: 2,3372016: 2,2522017: 2,4892018: 2,8552019: 2,9022020: 2,8892021: 3,0062022: 2,6432023: 3,0492024: 3,1902025: 3,056
2007high 3,190 (2024) · low 313 (2007)2025

MAUDE reports naming product code DQY, not matched to any one device; reports are not rates.

View these four charts as a table
YearDecisionsMedian 510(k) review, daysRecalls (Class I)MAUDE reports
200716856313
2008316612496
2009377317819
20102274321,293
2011367161,211
2012308721,191
2013329236 (1)1,352
20141912731,497
20152711832,337
20162211722 (7)2,252
20172611382,489
20182510622,855
20193011112,902
20202012022,889
2021188123,006
2022187402,643
202318114173,049
2024168713,190
2025211151 (1)3,056
202611302 (1)—

What is it indicated for?

The Precious Plus Guide Catheter is intended for use in coronary artery applications and

is designed to provide a pathway through which medical instruments, such as balloon

catheters, guide wires or other therapeutic devices may be introduced. These devices

are not intended for use in the cerebral vasculature.

Indications for use as stated in the FDA summary.

Cite this page

510(k) Report. “K072316: Precious Plus Guide Catheter.” Lineage record from FDA 510(k) data and the FDA summary. Updated Nov 3, 2026. Accessed Nov 5, 2026. https://510kreport.com/device/K072316

Report an extraction error

Tell us what is wrong; we check it against the FDA summary.

Are you the manufacturer?

Send a correction or an update to this page, for example a newer model or a public statement about a recall.

Record history
  • FDA decision record loaded May 2, 2026
  • Summary read Oct 13, 2026 (extraction version 9eaa42aa01ed)
  • Lineage and recalls computed Nov 3, 2026
  • Page last updated Nov 3, 2026